PolTREG CEO Trzonkowski co-authors peer-reviewed article showing scientific progress in T-reg autoimmune therapy

30.01.2024 -                Gdańsk, Poland – 30 January 2024 – PolTREG S.A. (Warsaw Stock Exchange: PTG) , a clinical-stage biotechnology company developing cell therapies for a wide range of autoimmune diseases, announced that Prof. Piotr Trzonkowski, CEO, ... Seite 1

Related Keywords

Poland ,Anke Fuchs ,Natalia Marek Trzonkowska ,Piotr Trzonkowski ,Technical University Of Dresden ,Poltreg Sa Warsaw Stock Exchange ,University Of Gda ,International Centre For Cancer Vaccine Science ,Ye Htun Oo At University Of Birmingham ,Warsaw Stock Exchange ,Multiple Sclerosis ,Medical University ,Technical University ,International Centre ,Cancer Vaccine Science ,Poltreg Spolka Akcyjna Chart ,Oltreg Spolka Akcyjna Kurs ,Oltreg Spolka Akcyjna Aktie ,